Evidence map›Paper›PMID 35295999›Full record

ArticleFrontiers in oncology2022

The Lymph Node Microenvironment May Invigorate Cancer Cells With Enhanced Metastatic Capacities.

Tianhang Li, Tianyao Liu, Zihan Zhao, Xinyan Xu, Shoubin Zhan, Shengkai Zhou, Ning Jiang, Wenjie Zhu, Rui Sun, Fayun Wei and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tianhang LiDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Tianyao LiuDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Zihan ZhaoDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Xinyan XuDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Shoubin ZhanJiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Shengkai ZhouJiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Ning JiangNanjing Drum Tower Hospital Clinical College of Jiangsu University, Nanjing, China.
Wenjie ZhuDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Rui SunDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Fayun WeiDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Baofu FengDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Hongqian GuoDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Rong YangDepartment of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer metastasis, a typical malignant biological behavior involving the distant migration of tumor cells from the primary site to other organs, contributed majorly to cancer-related deaths of patients. Although constant efforts have been paid by researchers to elucidate the mechanisms of cancer metastasis, we are still far away from the definite answer. Recently, emerging evidence demonstrated that cancer metastasis is a continuous coevolutionary process mediated by the interactions between tumor cells and the host organ microenvironment, and epigenetic reprogramming of metastatic cancer cells may confer them with stronger metastatic capacities. The lymph node served as the first metastatic niche for many types of cancer, and the appearance of lymph node metastasis predicted poor prognosis. Importantly, multiple immune cells and stromal cells station and linger in the lymph nodes, which constitutes the complexity of the lymph node microenvironment. The active cross talk between cancer cells and immune cells could happen unceasingly within the metastatic environment of lymph nodes. Of note, diverse immune cells have been found to participate in the formation of malignant properties of tumor, including stemness and immune escape. Based on these available evidence and data, we hypothesize that the metastatic microenvironment of lymph nodes could drive cancer cells to metastasize to further organs through epigenetic mechanisms.

Indexed as

epigenetic reprogrammingimmune escapelymph nodePD-L1stemnesstumor evolutiontumor metastasis

Identifiers

PMID35295999
PMCPMC8918682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.